Foghorn Therapeutics, Inc. (FHTX)
3.64
+0.01
(+0.28%)
USD |
NASDAQ |
Jun 03, 16:00
3.635
0.00 (0.00%)
Pre-Market: 19:59
Foghorn Therapeutics EPS Diluted (Quarterly) : -0.2858 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 2.878 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Anixa Biosciences, Inc. | -0.0772 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.88M |
| Revenue (Quarterly) | 3.267M |
| Total Expenses (Quarterly) | 23.14M |
| Enterprise Value | 70.82M |
| Gross Profit Margin (Quarterly) | 92.72% |
| Profit Margin (Quarterly) | -608.4% |
| Earnings Yield | -33.09% |
| Normalized Earnings Yield | -31.08 |